CAP and the American Society of Clinical Oncology (ASCO) today issued a joint guideline aimed at improving the accuracy of immunohistochemistry (IHC) testing for the expression status of estrogen (ER) and progesterone receptors (PgR) in breast cancer.
Read MoreAlverix announces that Richard Ric C. Tarbox, III has been named Chief Executive Officer of the company.
Read More
John T. Mather Memorial hospital cut C. difficile testing time by switching from a 3-day ELISA test to the Quik Chek Complete from Inverness Medical.
Read MoreResponse Genetics Inc, a company focused on the development and commercialization of molecular diagnostic tests for cancer, announced the addition of Michael B. McNulty as the Companys chief operating officer.
Read MoreVeracyte Inc announced the successful completion of its Series B round, a key milestone toward the companys first product launch later this year. Veracyte seeks to develop and commercialize molecular cytology solutions to improve the early and accurate diagnosis of cancer.
Read More